Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr;133(1):1-13.
doi: 10.1111/jnc.13033. Epub 2015 Feb 24.

The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease

Affiliations
Review

The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease

Laura J Blair et al. J Neurochem. 2015 Apr.

Abstract

Peptidyl-prolyl cis/trans isomerases (PPIases), a unique family of molecular chaperones, regulate protein folding at proline residues. These residues are abundant within intrinsically disordered proteins, like the microtubule-associated protein tau. Tau has been shown to become hyperphosphorylated and accumulate as one of the two main pathological hallmarks in Alzheimer's disease, the other being amyloid beta (Ab). PPIases, including Pin1, FK506-binding protein (FKBP) 52, FKBP51, and FKBP12, have been shown to interact with and regulate tau biology. This interaction is particularly important given the numerous proline-directed phosphorylation sites found on tau and the role phosphorylation has been found to play in pathogenesis. This regulation then affects downstream aggregation and oligomerization of tau. However, many PPIases have yet to be explored for their effects on tau biology, despite the high likelihood of interaction based on proline content. Moreover, Pin1, FKBP12, FKBP52, cyclophilin (Cyp) A, CypB, and CypD have been shown to also regulate Ab production or the toxicity associated with Ab pathology. Therefore, PPIases directly and indirectly regulate pathogenic protein multimerization in Alzheimer's disease and represent a family rich in targets for modulating the accumulation and toxicity.

Keywords: Alzheimer's disease; PPIase; amyloid β; chaperone; immunophilin; tau.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Potential dual role of Proline-directed Ser/Thr motifs in tau
Tau contains 43 Proline residues in the human 441-residue isoform that could be modified by either PPIases or kinases. Many of these Prolines are grouped together in the Proline-rich domain between 151 and 244 αα. Within this domain, only 13 of the 23 Ser/Thr residues are known to be phosphorylated, suggesting that some of these sites may exist to regulate tau structure. PPIases could control both tau phosphorylation and tau structure leading to its oligomerization.

Similar articles

Cited by

References

    1. Ahn J, Murphy M, Kratowicz S, Wang A, Levine AJ, George DL. Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction. Oncogene. 1999;18:5954–5958. - PubMed
    1. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta neuropathologica. 2002;103:26–35. - PubMed
    1. Bai X, Ma D, Liu A, Shen X, Wang QJ, Liu Y, Jiang Y. Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science. 2007;318:977–980. - PubMed
    1. Balastik M, Lim J, Pastorino L, Lu KP. Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism? Biochimica et biophysica acta. 2007;1772:422–429. - PMC - PubMed
    1. Barik S. Immunophilins: for the love of proteins. Cellular and molecular life sciences : CMLS. 2006;63:2889–2900. - PMC - PubMed

Publication types

MeSH terms